Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
3 "Mesenchymal stem cells"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Basic and Translational Research
Article image
Heterogeneity and Clinical Relevance of Human Adipose Stromal and Progenitor Cells
Maxi Albert, Khansa Nalir, Jiawei Zhong, Lucas Massier
Diabetes Metab J. 2026;50(2):217-234.   Published online March 1, 2026
DOI: https://doi.org/10.4093/dmj.2025.1182
  • 6,425 View
  • 175 Download
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Adipose stromal and progenitor cells (ASPCs) represent the largest cell population in human white adipose tissue (WAT). Despite their abundance, ASPC heterogeneity remains less well characterized compared to adipocytes or immune cells. Recent single-cell transcriptome studies provide unprecedented resolution of ASPC diversity and function. This review summarizes state-of-the-art approaches, including high-resolution single-cell methods, classical lineage and functional assays, to define ASPC populations. By systematically comparing recent datasets, we identify evidence for at least eight distinct ASPC-subtypes, which demonstrate specific marker genes and putative functional diversity. Along the adipogenic trajectory, these include uncommitted multipotent progenitors, intermediate and committed preadipocytes, and premature adipocytes. Additional populations comprise specialized anti-adipogenic, profibrotic, inflammatory, and fibroblast-like ASPCs. Other cell types are not consistently detected across studies, reflecting both biological and methodological variability, and the need for further validation studies. Better understanding of ASPC heterogeneity may improve the clinical assessment of metabolic disorders and support their treatment. We further discuss subtype-specific (dys)functions linked to fibrosis, inflammation and impaired adipogenesis and describe their increased abundance in metabolic disease. Together, this review integrates current knowledge on ASPC heterogeneity and highlights its clinical relevance, aiming to provide a unified framework for future studies on WAT remodeling and metabolic dysfunction.

Citations

Citations to this article as recorded by  
  • Cellular remodeling of lipedema affected subcutaneous adipose tissue
    Sabrina Gohlke, Francisco Garcia-Carrizo, Robin Upmeyer, Tim J. Schulz
    Frontiers in Cell and Developmental Biology.2026;[Epub]     CrossRef
Original Article
Basic Research
Article image
Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
Diabetes Metab J. 2021;45(2):260-269.   Published online July 10, 2020
DOI: https://doi.org/10.4093/dmj.2019.0191
  • 19,223 View
  • 264 Download
  • 18 Web of Science
  • 17 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Umbilical cord-mesenchymal stem cell-conditioned medium (UC-MSC-CM) has emerged as a promising cell-free therapy. The aim of this study was to explore the therapeutic effects of UC-MSC-CM on insulin resistance in C2C12 cell.

Methods

Insulin resistance was induced by palmitate. Effects of UC-MSC-CM on insulin resistance were evaluated using glucose uptake, glucose transporter type 4 (GLUT4) translocation, the insulin-signaling pathway, and mitochondrial contents and functions in C2C12 cell.

Results

Glucose uptake was improved by UC-MSC-CM. UC-MSC-CM treatment increased only in membranous GLUT4 expression, not in cytosolic GLUT4 expression. It restored the insulin-signaling pathway in insulin receptor substrate 1 and protein kinase B. Mitochondrial contents evaluated by mitochondrial transcription factor A, mitochondrial DNA copy number, and peroxisome proliferator-activated receptor gamma coactivator 1-alpha were increased by UC-MSC-CM. In addition, UC-MSC-CM significantly decreased mitochondrial reactive oxygen species and increased fatty acid oxidation and mitochondrial membrane potential. There was no improvement in adenosine triphosphate (ATP) contents, but ATP synthesis was improved by UC-MSC-CM. Cytokine and active factor analysis of UC-MSC-CM showed that it contained many regulators inhibiting insulin resistance.

Conclusion

UC-MSC-CM improves insulin resistance with multiple mechanisms in C2C12 cell.

Citations

Citations to this article as recorded by  
  • Innovative diabetes mellitus treatment strategies: Mesenchymal stem cell-based therapy and its impact on pro- and anti-inflammatory cytokines modulation
    Amin Ullah, Yutao Wu, Rajeev K. Singla, Weidong Tian, Bairong Shen
    Journal of Pharmaceutical Analysis.2026; 16(6): 101497.     CrossRef
  • Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives
    Hua Jiang, Hui Wang, Yankun Zhu, Chunyan Yi, Jinli Liu, Ruisi Zhao, Jianpeng Gao, Anmin Cao, Yangfan Guo
    Stem Cell Reviews and Reports.2026; 22(7): 3117.     CrossRef
  • Mesenchymal stem cell therapy for diabetes: clinical evidence, emerging strategies, and future perspectives
    Han-Ying Jhuang, Jo-Yu Lee, Li-Tzu Wang
    Metabolism.2026; 184: 156748.     CrossRef
  • Role of insulin resistance in atherosclerosis: underlying mechanisms and emerging stem cell-based therapeutic strategies
    Qiuwang Zhang, Yingen Chen, Di Wang, Sandra Pereira, Michael J. B. Kurtyk
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Ameliorative Effect of Combined Placenta-Derived Mesenchymal Stem Cells plus Platelet-rich Plasma on Polycystic Ovarian Model in Rats: A Biochemical and Histological Study
    Mojtaba Sarvestani, Alireza Rajabzadeh, Morteza Salimian, Tahereh Mazoochi, Gholamreza Ghavipanjeh
    Reproductive Sciences.2025; 32(3): 907.     CrossRef
  • Regenerative therapeutic effects of conditioned medium from human umbilical cord‑derived mesenchymal stem cells as an adjuvant to insulin therapy in a rat model of type 2 diabetes
    Siufui Hendrawan, Jennifer Lheman, Olivia Marcelina, Lydia Tantoso, Hans Baer, Shirly Gunawan
    World Academy of Sciences Journal.2025; 7(6): 1.     CrossRef
  • A Systematic Review of Palmitate-Mediated Insulin Resistance in C2C12 Myotubes
    John M. Zimmerman, Alexa J. Klein, Kipton B. Travis, Roger A. Vaughan
    Nutrients.2025; 17(22): 3619.     CrossRef
  • Wharton’s Jelly Mesenchymal Stem Cell Conditioned Medium Ameliorates Diabetes‐Induced Testicular Damage and Sperm Abnormalities by Mitigating Oxidative Stress, Apoptosis, and Inflammation
    Mojtaba Sargazi, Narges Karbalaei, Saied Karbalay-Doust, Sara Keshtgar, Zohre Aghaei, Pasquale Marrazzo
    Stem Cells International.2024;[Epub]     CrossRef
  • Secretome Derived from Mesenchymal Stem/Stromal Cells: A Promising Strategy for Diabetes and its Complications
    ling li, Siyu Hua, Lianghui You, Tianying Zhong
    Current Stem Cell Research & Therapy.2024; 19(10): 1328.     CrossRef
  • Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance
    Amnah Al-Sayyar, Maha M. Hammad, Michayla R. Williams, Mohammed Al-Onaizi, Jehad Abubaker, Fawaz Alzaid
    Metabolites.2023; 13(3): 384.     CrossRef
  • Neuroprotective Effect of Wharton’s Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis
    Zohre Aghaei, Narges Karbalaei, Mohammad Reza Namavar, Masoud Haghani, Mahboobeh Razmkhah, Mahdi Khorsand Ghaffari, Marzieh Nemati, Andrea Ballini
    Stem Cells International.2023; 2023: 1.     CrossRef
  • Mesenchymal-Stem Cell-Derived Conditioned Media Versus Exosomes in the Treatment of Rat Model of Polycystic Ovary: An Attempt to Understand the Underlying Mechanisms (Biochemical and Histological Study)
    Soha Abd-elkawy Abd-elwahab, Noura Hassan Khamis, Rehab Ahmed Rifaai, Nashwa Fathy Gamal El-Tahawy, Randa Ahmed Ibrahim
    Microscopy and Microanalysis.2023; 29(3): 1244.     CrossRef
  • Therapeutic Potential of Mesenchymal Stem Cell‐Derived Conditioned Medium for Diabetes Mellitus and Related Complications
    Basak Isildar, Serbay Ozkan, Meral Koyuturk
    Advanced Therapeutics.2023;[Epub]     CrossRef
  • Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
    Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich
    Human Cell.2023; 37(1): 54.     CrossRef
  • Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation
    Francesca Paris, Valeria Pizzuti, Pasquale Marrazzo, Andrea Pession, Francesco Alviano, Laura Bonsi
    International Journal of Molecular Sciences.2022; 23(23): 14597.     CrossRef
  • Mesenchymal Stem Cell-Derived Apoptotic Bodies: Biological Functions and Therapeutic Potential
    Huixue Tang, Huikun Luo, Zihan Zhang, Di Yang
    Cells.2022; 11(23): 3879.     CrossRef
  • Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach
    Andreia Gomes, Pedro Coelho, Raquel Soares, Raquel Costa
    Cell and Tissue Research.2021; 385(3): 497.     CrossRef
Review
Obesity and Metabolic Syndrome
Adult Stem Cells: Beyond Regenerative Tool, More as a Bio-Marker in Obesity and Diabetes
Sabyasachi Sen
Diabetes Metab J. 2019;43(6):744-751.   Published online December 26, 2019
DOI: https://doi.org/10.4093/dmj.2019.0175
  • 11,334 View
  • 86 Download
  • 6 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   ePub   

Obesity, diabetes, and cardiovascular diseases are increasing rapidly worldwide and it is therefore important to know the effect of exercise and medications for diabetes and obesity on adult stem cells. Adult stem cells play a major role in remodeling and tissue regeneration. In this review we will focus mainly on two adult stem/progenitor cells such as endothelial progenitor cells and mesenchymal stromal cells in relation to aerobic exercise and diabetes medications, both of which can alter the course of regeneration and tissue remodelling. These two adult precursor and stem cells are easily obtained from peripheral blood or adipose tissue depots, as the case may be and are precursors to endothelium and mesenchymal tissue (fat, bone, muscle, and cartilage). They both are key players in maintenance of cardiovascular and metabolic homeostasis and can act also as useful biomarkers.

Citations

Citations to this article as recorded by  
  • Stem cells in regenerative medicine: Unlocking therapeutic potential through stem cell therapy, 3D bioprinting, gene editing, and drug discovery
    Idris Zubairu Sadiq, Fatima Sadiq Abubakar, Babangida Sanusi Katsayal, Bashiru Ibrahim, Auwal Adamu, Mohammed Aliyu Usman, Mukhtar Aliyu, Mukhtar Adeiza Suleiman, Aliyu Muhammad
    Biomedical Engineering Advances.2025; 9: 100172.     CrossRef
  • Adipose-derived stem cell exosomes: emerging roles and therapeutic application
    Yuhan Gong, Hui Ma, Zhongren Zheng, Xinjie Wang, Jiahua Zhang, Xiaowei Zhao
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Novel Therapeutics in Nonalcoholic Fatty Liver Disease: A Focus on Adult Stem Cells
    Seshagiri Rao Nandula, Eric S. Nylen, Sabyasachi Sen
    Metabolic Syndrome and Related Disorders.2023; 21(2): 71.     CrossRef
  • Obesity and Wound Healing: Focus on Mesenchymal Stem Cells
    Antonio Alma, Guya Diletta Marconi, Elena Rossi, Cristina Magnoni, Alessia Paganelli
    Life.2023; 13(3): 717.     CrossRef
  • Stem Cells in Tendon Regeneration and Factors governing Tenogenesis
    Lingli Ding, BingYu Zhou, Yonghui Hou, Liangliang Xu
    Current Stem Cell Research & Therapy.2022; 17(6): 503.     CrossRef
  • Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes
    Seshagiri Rao Nandula, Nabanita Kundu, Hassan B. Awal, Beda Brichacek, Mona Fakhri, Nikhila Aimalla, Adrian Elzarki, Richard L. Amdur, Sabyasachi Sen
    Cardiovascular Diabetology.2021;[Epub]     CrossRef
  • Tailored generation of insulin producing cells from canine mesenchymal stem cells derived from bone marrow and adipose tissue
    Watchareewan Rodprasert, Sirirat Nantavisai, Koranis Pathanachai, Prasit Pavasant, Thanaphum Osathanon, Chenphop Sawangmake
    Scientific Reports.2021;[Epub]     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP